Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
Chubb
Deloitte
Argus Health
Federal Trade Commission
Healthtrust
Novartis
Accenture
AstraZeneca
Express Scripts

Generated: January 19, 2018

DrugPatentWatch Database Preview

CHLORPHENIRAMINE MALEATE Drug Profile

« Back to Dashboard

Which patents cover Chlorpheniramine Maleate, and when can generic versions of Chlorpheniramine Maleate launch?

Chlorpheniramine Maleate is a drug marketed by Aurolife Pharma Llc, Bel Mar, Elkins Sinn, Watson Labs, Pharm Assoc, Avanthi Inc, Anabolic, Bell Pharma, Impax Labs, Ivax Sub Teva Pharms, Kv Pharm, Lederle, Newtron Pharms, Panray, Pharmavite, Pharmeral, Pioneer Pharms, Purepac Pharm, Pvt Form, Roxane, Sun Pharm Industries, Vitarine, and West Ward. and is included in thirty NDAs.

The generic ingredient in CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate. There are twenty-nine drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the chlorpheniramine maleate profile page.
Drug patent expirations by year for CHLORPHENIRAMINE MALEATE
Medical Subject Heading (MeSH) Categories for CHLORPHENIRAMINE MALEATE

US Patents and Regulatory Information for CHLORPHENIRAMINE MALEATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080791-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 085139-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Aurolife Pharma Llc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate CAPSULE, EXTENDED RELEASE;ORAL 070797-001 Aug 12, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Panray CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 083243-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Roxane CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080626-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharm Assoc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate SYRUP;ORAL 087520-001 Feb 10, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs CHLORPHENIRAMINE MALEATE chlorpheniramine maleate INJECTABLE;INJECTION 083593-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Elkins Sinn CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 080938-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmeral CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET;ORAL 083753-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Avanthi Inc CHLORPHENIRAMINE MALEATE chlorpheniramine maleate TABLET, EXTENDED RELEASE;ORAL 040829-001 May 13, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Covington
Cipla
Cantor Fitzgerald
Boehringer Ingelheim
UBS
Teva
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot